Novo Nordisk Latvia, SIA
Informational products
Full company profile
Annual report 2024
One day access
Basic data
| Status | Active
|
|---|---|
| Business form | Limited Liability Company |
| Registered name | Novo Nordisk Latvia SIA |
| Registration number, date | 40203480485, 28.04.2023 |
| VAT number | LV40203480485 from 04.09.2023 Check SRS online VAT payers |
| Europe VAT register | |
| Register, date | Commercial Register, 28.04.2023 |
| Legal address | Kārļa Ulmaņa gatve 119, Mārupe, Mārupes nov., LV-2167 Check address owners |
| Fixed capital | 200 000 EUR, registered payment 28.04.2023 |
| CSDD | Transport vehicles registered in CSDD |
Important facts
- No active pledges
- No security means
- No economic activity cessation
- No activity restrictions
- Preform with profit
- Show AML risks
- Nav ieraksti maksātnespējas reģistrā
- No liquidations
- No reorganizations
- No contacts information
- Positive owned capital
- Check online actual tax payments in SRS
- Request debt return with VERDIKTS
- Good performance of obligations
Actual overdue payments
Request debt return with VERDIKTS
| Date | Case number | Status |
|---|---|---|
| None |
Taxes payments to government budget
| 2024 | 2023 | |
|---|---|---|
| Total payments to state budget (thousands, €) | 1 081.67 | 70.65 |
| Personal income tax (thousands, €) | 267.99 | 30.65 |
| Statutory social insurance contributions (thousands, €) | 440.15 | 51.98 |
| Average employees count | 21 | 7 |
Industries
| Field from SRS
Redakcija NACE 2.1 |
Farmaceitisku produktu un medicīnas preču vairumtirdzniecība (46.46) |
|---|---|
| CSP industry
Redakcija NACE 2.1 |
Farmaceitisku produktu un medicīnas preču vairumtirdzniecība (46.46) |
True beneficiaries
| True beneficiary | Time | Place of permanent residence | Nationality |
|---|---|---|---|
| Natural person | From 03.02.2026 | Italy | Italy |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
| Natural person | From 03.02.2026 | Denmark | Denmark |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
| Natural person | From 03.02.2026 | United States of America | United States of America |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
| Natural person | From 03.02.2026 | Denmark | Denmark |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
| Natural person | From 03.02.2026 | Denmark | Denmark |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
| Natural person | From 03.02.2026 | Denmark | Denmark |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
| Natural person | From 03.02.2026 | Denmark | Denmark |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
| Natural person | From 03.02.2026 | Denmark | Denmark |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
| Natural person | From 03.02.2026 | Denmark | Denmark |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
| Natural person | From 03.02.2026 | Denmark | Denmark |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
| Natural person | From 03.02.2026 | Denmark | Denmark |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
| Natural person | From 03.02.2026 | Denmark | Denmark |
|
Control type: nature_of_control.VIA_LEGAL_ARRANGEMENT_AS_TRUSTEE_MANAGER |
|||
Officials
| Name | Institution | Position | Representation/signatory powers | Notes | From* |
|---|---|---|---|---|---|
Natural person |
Executive Board | Member of the Board | Jointly with at least 1 | 03.02.2026 | |
Natural person |
Executive Board | Member of the Board | Jointly with at least 1 | 03.02.2026 | |
Natural person |
Executive Board | Member of the Board | Jointly with at least 1 | 03.02.2026 |
Members
| Name, address | Share, % | Number of shares | Share value | Total | Country | From | ER Registered |
|---|---|---|---|---|---|---|---|
Novo Nordisk Region Europe A/SReg. no. 26236266
|
100 % | 200 | € 1 000 | € 200 000 | Denmark | 26.01.2026 | 03.02.2026 |
Procures
| Period | Rights | Person |
|---|---|---|
From 03.08.2023 |
Jointly with the "prokurist" With rights to alienate property With rights to mortgage property With rights to burden property |
Natural person
(from 03.08.2023 )
Natural person
(from 03.08.2023 )
|
Annual reports
| Year | Period | Received | Type of delivery | Price | |
|---|---|---|---|---|---|
2024 |
Annual report | 01.01.2024 - 31.12.2024 | 30.06.2025 | ZIP | €7.00 |
| Annual report 2024 | |||||
| Revidentu zinojums NN 2024 | |||||
| Vadibas zinojums NN LV FS 2024 | |||||
2023 |
Annual report | 29.04.2023 - 31.12.2023 | 17.07.2024 | ZIP | €11.00 |
| Annual report 2023 | |||||
| Neatkar ga revidenta zi ojums 2023 signed | |||||
| SIA Novo Nordisk Vad bas zi ojums 2023 signed |
Documents
| Type | Format | Size | Added | Document date | Number of pages |
|---|---|---|---|---|---|
Shareholders’ register |
278.23 KB | 28.01.2026 | 26.01.2026 | 1 | |
Documents confirming the registration of a foreign company (statement from the register) and translations thereof |
EDOC | 199.43 KB | 25.04.2023 | 17.03.2023 | 41 |
Shareholders’ register |
TIF | 244.88 KB | 26.04.2023 | 07.03.2023 | 13 |
Articles of Association |
EDOC | 49.16 KB | 27.04.2023 | 07.02.2023 | 7 |
Restricted documents
available by request to LR Company register
| Type | Format | Size | Added | Document date | Number of pages |
|---|---|---|---|---|---|
Justification supporting beneficial ownership disclosure statement |
83.07 KB | 03.02.2026 | 03.02.2026 | 34 | |
Justification supporting beneficial ownership disclosure statement |
268.69 KB | 03.02.2026 | 03.02.2026 | 143 | |
Justification supporting beneficial ownership disclosure statement |
104.17 KB | 03.02.2026 | 03.02.2026 | 44 | |
Justification supporting beneficial ownership disclosure statement |
6.21 MB | 03.02.2026 | 03.02.2026 | 8 | |
Justification supporting beneficial ownership disclosure statement |
55.69 KB | 03.02.2026 | 03.02.2026 | 20 | |
Justification supporting beneficial ownership disclosure statement |
302.87 KB | 03.02.2026 | 29.01.2026 | 2 | |
Application |
849.78 KB | 28.01.2026 | 28.01.2026 | 29 | |
Copy of the personal identification document |
163.31 KB | 28.01.2026 | 22.01.2026 | 1 | |
Copy of the personal identification document |
157.28 KB | 28.01.2026 | 22.01.2026 | 1 | |
Copy of the personal identification document |
165.06 KB | 28.01.2026 | 15.01.2026 | 1 | |
Copy of the personal identification document |
162.83 KB | 28.01.2026 | 15.01.2026 | 1 | |
Copy of the personal identification document |
157.28 KB | 28.01.2026 | 13.01.2026 | 1 | |
Copy of the personal identification document |
152.57 KB | 28.01.2026 | 12.01.2026 | 1 | |
Copy of the personal identification document |
154.49 KB | 28.01.2026 | 10.01.2026 | 1 | |
Copy of the personal identification document |
141.29 KB | 28.01.2026 | 10.01.2026 | 1 | |
Copy of the personal identification document |
143.83 KB | 28.01.2026 | 06.01.2026 | 1 | |
Copy of the personal identification document |
1.48 MB | 28.01.2026 | 02.01.2026 | 10 | |
Copy of the personal identification document |
158.54 KB | 28.01.2026 | 20.12.2025 | 1 | |
Copy of the personal identification document |
144.35 KB | 28.01.2026 | 18.12.2025 | 1 | |
Justification supporting beneficial ownership disclosure statement |
1.05 MB | 28.01.2026 | 04.12.2025 | 12 | |
Consent of a member of the Board / executive director |
170.92 KB | 06.10.2025 | 16.07.2025 | 1 | |
Consent of a member of the Board / executive director |
170.92 KB | 06.10.2025 | 16.07.2025 | 1 | |
Consent of a member of the Board / executive director |
172.96 KB | 06.10.2025 | 16.07.2025 | 1 | |
Protocols/decisions of a company/organisation |
TIF | 165.72 KB | 07.10.2025 | 03.07.2025 | 11 |
Application |
EDOC | 46.47 KB | 03.08.2023 | 03.08.2023 | 2 |
Protocols/decisions of a company/organisation |
TIF | 7.81 MB | 02.08.2023 | 20.06.2023 | 15 |
Justification supporting beneficial ownership disclosure statement |
DOCX | 182.96 KB | 28.04.2023 | 28.04.2023 | 1 |
Justification supporting beneficial ownership disclosure statement |
92.4 KB | 28.04.2023 | 28.04.2023 | 1 | |
Justification supporting beneficial ownership disclosure statement |
22.25 KB | 28.04.2023 | 28.04.2023 | 1 | |
Justification supporting beneficial ownership disclosure statement |
247.06 KB | 28.04.2023 | 28.04.2023 | 1 | |
Justification supporting beneficial ownership disclosure statement |
17.72 KB | 28.04.2023 | 28.04.2023 | 1 | |
Application |
EDOC | 50.95 KB | 27.04.2023 | 27.04.2023 | 5 |
Bank statements or other document regarding the payment of the equity |
EDOC | 30.65 KB | 25.04.2023 | 07.03.2023 | 1 |
Protocols/decisions of a company/organisation |
EDOC | 44.12 KB | 27.04.2023 | 07.02.2023 | 3 |
Power of attorney, act of empowerment |
TIF | 409.27 KB | 26.04.2023 | 07.02.2023 | 12 |
Consent of a member of the Board / executive director |
TIF | 170.27 KB | 26.04.2023 | 03.02.2023 | 8 |
Announcement regarding the legal address |
TIF | 597.61 KB | 28.04.2023 | 01.02.2023 | 1 |
Consent of a member of the Board / executive director |
TIF | 134.96 KB | 26.04.2023 | 25.01.2023 | 6 |
Consent of a member of the Board / executive director |
TIF | 245.74 KB | 26.04.2023 | 30.12.2022 | 10 |